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Previously, we described the derivation of a pathogenic strain of simian–human immunodeficiency virus (SHIVKU-2)
consisting of the tat, rev, vpu, and env genes of HIV-1 (strain HXB2) in a genetic background of SIVmac239 that causes AIDS
and productive infection of the CNS in rhesus macaques (Macca mulatta) (Raghavan et al., 1997, Brain Pathol. 7, 851–861).
We report here on the characterization of a molecular clone of SHIVKU-2, designated SHIVKU-2MC4, that caused CD4
1 T cell loss
as well as neurological and renal disease in macaques. DNA sequence analysis of selected SIV regions of SHIVKU-2MC4
revealed 10 nucleotide changes in the LTR, whereas Gag, Vif, Vpr, Vpx, and Nef had 1, 1, 1, 2, and 13 predicted amino acid
substitutions, respectively, compared to SIVmac239. DNA sequence analysis of HIV-1 derived regions of SHIVKU-2MC4 revealed
2, 1, 2, and 18 predicted amino acid substitutions in the Tat, Rev, Vpu, and Env proteins, respectively, when compared to
SHIV-4. Unlike the parental SHIV-4, which is not tropic for macrophages, SHIVKU-2MC4 replicated efficiently in macrophage
cultures as determined by p27 assays. However, despite the numerous changes in the Env protein and newly acquired
tropism for macrophages, SHIVKU-2MC4, like the parental SHIV-4, used CXCR4 exclusively as its coreceptor for entry into
susceptible cells. Inoculation of SHIVKU-2MC4 into two rhesus macaques resulted in severe infection in which the numbers of
circulating CD41 T cells in the blood declined rapidly by 2 weeks postinoculation and virus producing cells in the peripheral
blood mononuclear cells were identified throughout the course of infection. At the time of euthanasia (20 and 22 weeks), both
macaques had lost a significant amount of weight and had no circulating CD41 T cells. In addition, one macaque developed
intension tremors and uncoordinated movements. Virological examination of tissues at necropsy revealed active virus
replication in both lymphoid and nonlymphoid tissues such as the lung and brain. Histological examination revealed that the
induced immunodeficiency was associated with lymphoid depletion of the lymph nodes and spleen, opportunistic infections,
lentiviral encephalitis, and severe glomerulosclerosis of the kidney. This molecular clone will serve as the basis for analyzing
the molecular determinants through which SHIVKU-2 causes severe CD4
1 T cell loss, neurological disease, and SHIV
nephropathy in rhesus macaques. © 1999 Academic Press
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aINTRODUCTION
The recent development of chimeric simian–human
mmunodeficiency viruses (SHIV) containing the tat, rev,
pu, and env genes of HIV-1 that cause AIDS in ma-
aques (Joag et al., 1996; Karlsson et al., 1997; Shibata et
l., 1998) has provided a new nonhuman primate model
f HIV-1 disease, distinct from that caused by pathogenic
IV. By expressing the envelope glycoprotein of HIV-1,
he SHIV model provides a mechanism for studying the
iology of structural motifs unique to gp160 of HIV-1
ithin the context of infection and disease in an animal
ather than in a cell culture system. Such motifs include
ites in the virus envelope glycoprotein that are respon-
ible for viral cell and tissue tropisms, coreceptor usage,
nd epitopes responsible for inducing neutralizing anti-
1 To whom correspondence and reprint requests should be ad-
mressed. Fax: (913) 588-7295. E-mail: estephen@kumc.edu.
295odies to HIV. Further, the model provides a mechanism
or studying the variable regions unique to the env gene
f HIV-1 and the effects of mutations in these variable
egions on the biological properties of SHIV. In addition
o the studies on the env gene of HIV-1, the SHIV model
lso provides a format for evaluating the biological ef-
ects of the HIV-1-specific accessory gene vpu. During
he derivation of the pathogenic SHIVKU-1 virus, we found
hat increased changes occurred in env and nef only
fter the vpu gene reverted to a functional gene, sug-
esting a role for this gene in the pathogenesis of
HIVKU-1 in macaques (McCormick-Davis et al., 1998).
The most important impact of the SHIV model has
een its pathogenic manifestations. All of the pathogenic
HIVs replicate to extremely high titers early in infection
n macaques and this is accompanied by a rapid, sub-
otal loss of CD41 T cells (Joag et al., 1996; Karlsson et
l., 1997; Shibata et al., 1998). Most SHIV-infected ani-
als develop AIDS within 8 months (Joag et al., 1996;
0042-6822/99 $30.00
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296 LIU ET AL.arlsson et al., 1997; Shibata et al., 1998). The SHIVKU
odel has been used further to show that infection and
isease can be initiated from the vaginal and oral mu-
osal surfaces and infection can be prevented by pre-
reatment of animals with neutralizing serum (Foresman
t al., 1998) and disease by prior immunization with safe,
ive-virus vaccines (Joag et al., 1998b). Further, mutations
n the env and nef genes together with a functional vpu
ene correlated with the acquisition of macrophage tro-
ism, complementing the tropism of the virus for CD41 T
ells. This dual tropism in turn correlated with the ability
f the virus to cause fatal infection after inoculation on
ucosal surfaces and also to cause neurological dis-
ase as a complication of loss of CD41 T cells and AIDS
Raghavan et al., 1997; Joag et al., 1998a). In this report,
e describe the construction, derivation, and character-
zation of a new molecular clone of SHIVKU-2, which, upon
noculation into rhesus macaques, caused loss of CD41
cells, AIDS, encephalitis, and glomerulosclerosis.
RESULTS
erivation of the SHIVs used in this study
All of the SHIVs in this study were derivatives of the
onpathogenic SHIV-4 virus, which contains the tat, rev,
pu, and env genes from the HXB2 strain of HIV-1 in a
enetic background of SIVmac239 (Li et al., 1992). SHIVKU-1
s an uncloned virus isolated from the cerebrospinal fluid
CSF) of a pig-tailed macaque that developed severe
D41 T cell loss and AIDS (Joag et al., 1996; Stephens et
l., 1997). SHIVKU-2 is an uncloned virus isolated from the
SF of rhesus macaque 14A following inoculation with
HIVKU-1 and cells containing infectious virus from ma-
aque PPc (Raghavan et al., 1997; Joag et al., 1998a).
olecular characterization of SHIVKU-2MC4
DNA sequence analysis of SHIVKU-2MC4 was performed to
ompare the changes that occurred in this pathogenic virus
ith those of the nonpathogenic parental SHIV-4. Results of
hese analyses are shown in Table 1. With respect to the
IVmac regions, the 59 LTR had 10 nucleotide substitutions,
hereas Gag, Vif, Vpx, Vpr, and Nef had 1, 1, 1, 2, and 13
redicted amino acid substitutions, respectively. With re-
pect to the HXB2-derived sequences, Tat, Rev, Vpu, and
nv had 2, 1, 2, and 18 predicted amino acid substitutions,
espectively. Twelve of the 18 predicted amino acid
hanges in Env were found in gp120 and eight in the
ariable domains (V1–V5) of gp120. Because SHIVKU-2MC4
as derived from the uncloned SHIVKU-2 virus, we compared
he consensus amino acid sequences of Env and Nef of
HIVKU-2 with that of SHIVKU-2MC4 (Figs. 1 and 2). Of the 12
onsensus amino acid substitutions found in the gp120 of
ncloned SHIVKU-2, 11 were also found in SHIVKU-2MC4 (Fig. 1).
imilarly, of the 13 amino acid substitutions found in the Nef
f SHIVKU-2MC4, 11 were also found in the consensus amino ucid sequence of SHIVKU-2 (Fig. 2). Thus, there was good
greement between the changes found in SHIVKU-2MC4 and
hose found in the uncloned SHIVKU-2 virus.
HIVKU-2 is macrophage tropic
We analyzed the ability of SHIVKU-2MC4 to replicate in
hesus macrophage cultures. All four viruses, SHIV-4,
HIVKU-1, SHIVKU-2, and SHIVKU-2MC4, replicated to high tiers
n C8166 cells and in PHA-stimulated peripheral blood
ononuclear cells (PBMC), as determined by the release
f p27 during a 10-day period (data not shown). However,
he viruses varied greatly from one another in their effi-
iency of replication in PBMC-derived macrophages (Fig.
). Cultures inoculated with SHIVKU-2 and SHIVKU-2MC4 pro-
uced 14.6- and 10.1-fold more p27, respectively, than
ultures inoculated with SHIV-4. Thus, SHIVKU-2 and
HIVKU-2MC4 replicated at a higher efficiency in rhesus
acrophages than parental SHIV-4.
HIVKU-2MC4 uses CXCR4 exclusively as a coreceptor
or entry
We compared the abilities of SHIV-4 and SHIVKU-2MC4 to
TABLE 1
Amino Acid Substitutions in SIV and HIV-1 Regions of SHIVKU2MC4
Virus region Amino acid substitutions
HIV-1 (HXB2 strain)
Tat Q17K
S77P
Rev A68S
Vpu T1M
P76T
Env L10S T626M
V65A F673D
D130N I723T
K192T I780T
T202S T818I
N300S H842Y
R304I
I320M
D412G
N460K
S461G
SIVmac239
Gag T112I
Vif Y143H
Vpx R27K
Vpr G86E
M100I
Nef G3R Y133F
P12Q I143M
G23E E150K
S30R G208R
N72D E209K
D96N R245K
K104Rse 11 different chemokine and orphan seven transmem-
b
r
e
C
s
S
i
V
297ISOLATION OF A PATHOGENIC MOLECULAR CLONE OF SHIVKU-2rane domain receptors to infect cells. Pseudotyped vi-
uses containing the desired Env proteins and a lucif-
FIG. 1. Comparison of the consensus amino acid sequence of gp1
HIVKU-2 virus stock (designated 14ACSF 6, 8, 9, 10, and 11), and the cons
s the sequence of HXB2 gp160. Dashes represent amino acid identity.
2, V3, V4, and V5 were placed above the gp120 sequences.rase reporter gene were used to infect cells expressing pD4 and the indicated coreceptors (Fig. 4). As we have
hown previously (Hoffman et al., 1998), the Env from
molecular clone SHIVKU-2MC4, five clones isolated from the uncloned
sequence for the uncloned SHIVKU-2 virus. Shown above the sequences
parative purposes, brackets corresponding to the variable regions V1,60 from
ensus
For comarental lymphocyte-tropic SHIV-4, derived from HIV-1
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298 LIU ET AL.xB2, primarily used CXCR4 as a coreceptor (Hoffman et
l., 1998). Surprisingly, despite its acquisition of tropism
or macrophages, SHIVKU-2MC4 maintained primary usage
f the CXCR4 coreceptor (Fig. 4).
athogenesis of SHIVKU-2MC4 in rhesus macaques
Macaques 44N and 44O were inoculated intrave-
ously with 1 ml of virus and examined for virus replica-
ion and host responses. As shown in Fig. 5, both ani-
als developed a highly productive systemic infection.
t 2 weeks, both animals had a virus burden of infection
n more than 10,000 cells/106 PBMC. The infectivity in
BMC continued throughout the infection in both ani-
als. Plasma viremia was highest at 1 to 2 weeks post-
FIG. 1
FIG. 2. Comparison of the consensus amino acid sequence of Nef fro
irus stock (designated 14ACSF 7, 28, 29, 32, 35, and 36), and the co
equences is the sequence of SIVmac239 Nef (Regier and Desrosiers, 1990) wnoculation and was generally present throughout the
ourse of infection. Both animals experienced precipi-
ous loss of CD41 T cells during the first 2 weeks of
nfection, a finding typical for animals infected with
athogenic SHIVs (Joag et al., 1996; Karlsson et al., 1997;
hibata et al., 1998). The low CD41 T cell counts were
aintained throughout infection and by the time the
nimals had become moribund, the cell count was be-
ween 0 and 50. The CD81 T cell counts, however, were
aintained at normal levels throughout the infection ex-
ept for the last 2 weeks, when these cell counts also
eclined to very low levels. The animals maintained
ormal weights during the first 2 months of infection but
hey gradually lost weight and became cachectic by 20
inued
cular clone SHIVKU-2MC4, six clones isolated from the uncloned SHIVKU-2
s sequence of Nef for the uncloned SHIVKU-2 virus. Shown above them mole
nsensuith Nef corrected at codon 92. Dashes represent amino acid identity.
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299ISOLATION OF A PATHOGENIC MOLECULAR CLONE OF SHIVKU-2eeks postinoculation. By then, they had developed di-
rrhea and progressive cachexia. Macaque 44N was
uthanized at week 20. This animal developed ataxia
ith intension tremors 1 day before euthanasia. Ma-
aque 44O was euthanized at week 22 after it had be-
ome cachectic and anorexic. Neither macaque devel-
ped antibodies against SHIV Env and Gag proteins, a
inding similar to many macaques inoculated with patho-
enic SHIV (data not shown).
Virus burdens in various tissues of the two animals are
ummarized in Table 2 and showed severe infection in
isceral organs and the CNS. Infectivity was found in
ell-free homogenates from nearly all tissue samples
ncluding lung, lymph node, spleen, and several regions
f the brain. Further, explant cultures prepared from the
ung, spleen, and brain, yielding almost pure cultures of
acrophages from the particular tissues, all produced
irus, indicating pantropic infection in the macrophage
opulations of various tissues in the animals.
Histological examination of tissues of the animals
howed generalized depletion of cells from the lymphoid
issues of both animals similar to that reported in ani-
als dying from infection with uncloned SHIVKU-2 (Ragha-
an et al., 1997). In addition, there was histological evi-
ence of infection in the lungs of macaque 44O with
neumocystis carinii and evidence also of enterocolitis.
epatic tissues from neither macaque had histological
esions. Superimposed on this background, macaque
4O also developed focal leukoencephalomyelitis that
FIG. 3. Growth curve of SHIV-4, SHIVKU-1, SHIVKU-2, and SHIVKU-2MC4 in
hesus macrophage cultures. Rhesus macrophages in 35-mm dishes
ere prepared as described previously (Stephens et al., 1995). All
ultures were inoculated with 1000 TCID50 of each virus (an m.o.i. of
pproximately 0.01) for 2 h, washed three times to remove the virus
noculum, and maintained in the appropriate medium for the course of
nfection. Culture medium was harvested at the time points indicated
nd assayed for the presence of p27 antigen using antigen capture
ssays (Coulter Corp.). (F) SHIV-4 inoculated rhesus macrophage
ultures. (E) SHIVKU-1-inoculated rhesus macrophage cultures. (h)
HIVKU-2-inoculated rhesus macrophage cultures. (n) SHIVKU-4MC4-inoc-
lated rhesus macrophages.as disseminated throughout the brain and spinal cord tFigs. 6A and 6B). To test whether these white matter
esions were associated with viruses other than SHIV, we
xamined DNA from 16 regions of the brain and spinal
ord and used nested polymerase chain reaction (PCR)
o test for presence of SHIV, cytomegalovirus (CMV), and
V40. The results summarized in Table 3 showed that all
he regions were positive for SHIV DNA and none were
ositive for either CMV or SV40. Macaque 44N had
isseminated meningitis and focal encephalitis. Exami-
ation of various regions of the CNS showed that all 16
egions had SHIV sequences but 11 of these also had
MV and 10 had SV40 sequences. Both animals devel-
ped extensive renal glomerular pathology (Figs. 7B and
C) compared to normal macaque kidney (Fig. 7A). His-
opathological changes included proliferation of mesan-
ial cells, an increase in the mesangial matrix, and focal
egmental and global glomerulosclerosis. In both ma-
aques, over 60% of the glomeruli had developed glo-
erulosclerosis. Viral p27 was detected in the glomeruli
rom both macaques (Figs. 7E and 7F) and the viral
enome was isolated in lysates of purified preparations
f glomeruli by PCR using procedures previously de-
cribed (Gattone et al., 1998; Stephens et al., 1998).
inimal changes were found in the tubular regions of the
idneys. The extensive pathological changes were also
eflected in the renal function studies. Both macaques
ad developed proteinuria and were severely azotemic
SUN levels of 88 and 128.9 mg/dl) compared to unin-
ected macaques, which had no proteinuria and had
UN levels that averaged 23.8 mg/dl.
DISCUSSION
We report here on the isolation and biological charac-
erization of a molecular clone of SHIVKU-2 that caused
IDS and severe lentiviral complications in the CNS and
idneys of rhesus macaques. The virus caused massive
nfection in the animals as evidenced by the extremely
igh virus burdens in PBMC and cell-free infectivity in
lasma. The productive infection continued unabated
hroughout the course of infection in both animals al-
hough the intensity of virus replication declined after the
irst month, presumably correlating with the unavailability
f adequate numbers of target CD41 T cells necessary to
aintain the levels of virus replication observed earlier.
he infection lasted approximately 5 months. Both ani-
als developed severe AIDS-defining illnesses charac-
erized by diarrhea, pneumocystis pneumonia, severe
eight loss ending in cachexia, and eventually anorexia
nd reluctance to move. Both animals were euthanized
n a moribund state.
Histological analysis of tissues confirmed the severe
epletion of cells from lymphoid tissues, correlating with
he loss of immunocompetence by the animals. His-
opathologic changes in the CNS animals suggested that
he virus was also neurovirulent. The evidence was
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300 LIU ET AL.lear-cut in macaque 44O in that the disseminated focal
esions in the white matter correlated with the presence
f cell-free SHIV in homogenates of brain tissue and in
roductive infection in brain macrophages cultured from
rain tissue explants. This finding together with the fail-
re to detect evidence of infection in the brain of this
nimal with CMV and SV40, two of the most common
iral opportunistic pathogens in the CNS of victims of
IDS (Price and Brew, 1997), suggests that CMV and
V-40 coinfections were not required for SHIV to induce
NS lesions in this animal. The role of the virus in
esions in 44N was less clear-cut since DNA of SHIV and
NA of CMV and SV40 were all present in the CNS.
owever, SHIV could have played a significant role in the
europathogenesis process since macrophages from
rain explants produced virus, indicating a productive
nfection in brain macrophages with this virus.
In addition to lesions in the CNS, both animals devel-
ped severe pathologic changes in the glomeruli of the
idneys. These lesions are similar to those observed in
FIG. 4. Coreceptor use profile of the SHIVKU-2MC4 gp120 protein. Viral
nto 293T cells were used to infect feline CCCS target cells expressin
f the reporter virus genome and LTR-mediated production of lucifera
roteins are shown along the X-axis and activity for each coreceptor i
t least three times with three independently derived virus stocks. A re
nd served as a control for CCR5, GPR1, GPR15, and STRL33 expressumans with HIV-1-associated nephropathy and in ani- sals infected with macrophage-tropic SIVmacR71/17E but
istinct from the interstitial pathologic changes usually
ssociated with infection with lymphocyte-tropic
IVmac239 (D’Agati and Appel, 1997; Gattone et al., 1998;
tephens et al., 1998). Thus, whereas the loss of CD41 T
ells and immunocompetence in the two macaques
ere associated with a lytic infection in T cells, the
omplications in the CNS and kidneys were probably
ssociated with the macrophage-tropic nature of the
irus. While we have observed a similar pathology in the
idneys from some macaques inoculated with SHIVKU-2,
he extent was more severe with this cloned virus (data
ot shown). This dual tropism of the virus was confirmed
n studies on replication of the virus in macaque PBMC
nd PBMC-derived macrophage cultures.
The availability of a molecular clone that is dual tropic
or CD41 T lymphocytes and macrophages both in cell
ulture and in vivo provides a unique opportunity to study
he usage of coreceptors for virus entry into host cells. It
as been shown previously that both M- and T-tropic SIV
types generated by cotransfection of env and NL-luc-E2R2 constructs
and indicated coreceptor. Infection of target cells leads to integration
ich was quantified in cell lysates 3 days postinfection. Different Env
ted by relative light units on the Y-axis. Experiments were performed
tative experiment is shown. The clone BK28 from SIVmac251 is shownpseudo
g CD4
se, wh
s indica
presentrains use CCR5 as a coreceptor, while most T-tropic
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301ISOLATION OF A PATHOGENIC MOLECULAR CLONE OF SHIVKU-2IV-1 strains use CXCR4 and M-tropic strains use CCR5
Hoffman and Doms, 1997; Moore et al., 1997). In addi-
ion, some SIV strains can use the orphan seven trans-
embrane domain receptors GPR15 and STRL33 to in-
ect cells (Deng et al., 1998; Edinger et al., 1998b). Earlier
xamination of the coreceptor usage of SHIV-4, a virus
hat bears the classic T-cell tropic HIV-1 HxB2 Env pro-
ein, showed that this Env used CXCR4 exclusively. Sur-
FIG. 5. The levels of CD41 T cells (), numbers of cells producing in
4O (B) following inoculation with SHIVKU-2MC4.risingly, coreceptor usage by SHIVKU-2MC4 was also con- bined to CXCR4 despite its highly macrophage-tropic
ature.
Our results suggest that CXCR4 is expressed on rhe-
us macaque macrophages at levels sufficient to sup-
ort virus infection. It has been previously shown that
uman macrophages express CXCR4 and that the dual-
ropic HIV-1 strain 89.6 has been shown to use this
eceptor to infect this cell type (Yi et al., 1998). It should
s virus (n), and levels of plasma viremia (}) in macaques 44N (A) andfectioue pointed out that SHIVKU-2MC4 failed to replicate in hu-
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302 LIU ET AL.an macrophages despite its high efficiency of replica-
ion in macaque macrophages, and we did not perform
locking studies to confirm the use of CXCR4 in ma-
aque macrophages by SHIVKU-2MC4. It is therefore possi-
le that the tropism of this virus for macaque macro-
hages may be associated with coreceptors other than
hose currently recognized.
To lay future groundwork for analyzing the molecular
asis of virulence by SHIVKU-2MC4, we analyzed the nucle-
tide sequences in the envelope glycoprotein of the virus
nd compared them to parental SHIVKU-2. Analysis of the
ncloned SHIVKU-2 revealed a total of 12 and 6 consensus
mino acid substitutions in the gp120 and gp41 regions
f the Env, respectively, when compared to the parental
HIV-4 sequence. Sequence analysis of env from the
ncloned SHIVKU-2 showed similar amino acid substitu-
ions found in SHIVKU-2MC4 virus. Our analysis revealed
hat SHIVKU-2MC4 had 12 and 6 amino acid substitutions in
he gp120 and gp41 regions of Env, respectively, or a
.34% change in the predicted amino acid sequence
hen compared to SHIV-4. Eleven of 12 of the amino acid
ubstitutions found in the gp120 uncloned SHIVKU-2 virus
nd all 6 substitutions in gp41 were also represented in
HIVKU-2MC4. Surprisingly, we also found a total of 13 con-
ensus amino acid substitutions in Nef of SHIVKU-2MC4.
omparison of Nef from the uncloned and cloned viruses
evealed that all 11 consensus amino acid substitutions
ound in Nef from uncloned SHIVKU-2 were found in
HIVKU-2MC4. The 13 amino acid substitutions found in Nef
epresented a 4.94% change in the predicted amino acid
equence when compared to SHIV-4. Thus, our se-
uence analysis of the SHIVKU-2 virus and molecularly
loned SHIVKU-2MC4 indicated that the gene that under-
ent the most variation following passage of SHIVKU-1
nd cells containing infectious virus from macaque PPc
nto macaque 14A was nef. Previously, it was shown that
T
Evaluation of Virus Burden in M
Macaque Tissue ICAa
44N PBMC 10
Lymph node 1,000
Spleen 10
Brain ND
Lung ND
44O PBMC 100
Lymph node 100
Spleen 10,000
Brain ND
Lung ND
a Number of infectious cells per 106 as determined by cytopathology
b Expressed as log10 TCID50 per milliliter of virus recovered from PBM
c Virus recovered from explant cultures of spleen, brain, and lung tis
d Expressed as log10 TCID50 per milliliter of virus recovered from homeletion of the nef gene from SIVmac239 reduced the sathogenicity of this virus in adult macaques (Kestler et
l., 1990), and more recently, it was shown that Nef
arbors a major determinant of pathogenicity for the
IDS-like disease induced by HIV-1 in transgenic mice
Hanna et al., 1998). Other studies have shown that
mino acid substitutions within Nef can alter the patho-
enicity of SIV. Site-directed mutagenesis of nef of
IVmac239, a virus that generally causes AIDS in ma-
aques with a median time of 22 months following inoc-
lation (Kestler et al., 1990), yielded a virus that had
itogenic activity and caused a hyperacute
SIVsmmPBj14-like disease” following inoculation into pig-
ailed macaques (Fultz et al., 1989). In addition, it was
hown that the arginine to tyrosine change at position 17
f Nef was the only requirement necessary for conver-
ion of SIVmac239 to a virus with the lymphocyte-activat-
ng properties of SIVsmmPBj14 (Du et al., 1996). Whether
he changes in Nef are involved in multiple disease
yndromes (i.e., AIDS, neurological and renal disease)
nduced by SHIVKU-2MC4 will be assessed by interviral
ecombinants in which the nef of SHIVKU-2MC4 is replaced
ith that of nonpathogenic SHIV-4. Nevertheless, the
HIVKU-2MC4/rhesus macaque model should prove ex-
remely useful in analyzing the molecular determinants
nvolved in SHIV-induced disease in rhesus macaques.
MATERIALS AND METHODS
ells and viruses
The C8166 cell line was used as indicator cells to
easure infectivity and cytopathicity of the viruses used
n this study. C8166 cells were maintained in RPMI 1640,
upplemented with 10 mM HEPES buffer, pH 7.3, 2 mM
lutamine, 50 mg/ml gentamicin, and 10% fetal bovine
es 44N and 44O at Necropsy
/IL2b MDMc Virus from homogenatesd
.0 ND ND
.0 ND 3.9
.0 1 2.6
D 2 1.8
D 1 3.9
.0 ND ND
.0 ND 4.3
.0 1 4.3
D 1 3.4
D 1 3.8
. ND, not done.
res stimulated with PHA followed by culturing in the presence of IL-2.
rown in macrophage differentiation medium.
tes cultured with C8166 cells.ABLE 2
acaqu
PHA
4
4
2
N
N
4
4
2
N
N
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C cultu
sues gerum (R10FBS).
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303ISOLATION OF A PATHOGENIC MOLECULAR CLONE OF SHIVKU-2FIG. 6. Histopathological lesion associated with SHIVKU-2MC4 infection of rhesus macaque 44O. Low- (a) and high- (b) power magnification of a
ematoxylin and eosin stain of the basal ganglia showing a microglial nodule with multinucleated giant cells in white matter (magnification of a, 320;
, 3100).FIG. 7. Renal pathology and localization of viral p27 in the glomeruli from SHIVKU-2MC4-infected rhesus macaques. Shown is the renal cortex with the
ormal glomeruli (arrows) from a normal, uninfected macaque (A), the glomeruli of kidney of 44O (arrows), which are enlarged and more prominent
B), due to the increased amount of periodic acid-Schiff-positive matrix (pink staining material) and increased numbers of mesangial cells in this
clerotic glomerulus (C). Some tubules of 44O are dilated, exhibiting microcystic change (* in B). No SIV p27 protein is evident in normal uninfected
idneys or glomeruli (G1) (D); however, all glomeruli (arrows) in 44N (and 44O; not shown) showed some evidence of p27 staining (E), which is more
asily seen at higher magnification (F). Magnifications A, B, D, and E, 350; C and F, 3200.
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304 LIU ET AL.onstruction of molecular clones of SHIVKU-2
To generate infectious molecular clones of SHIVKU-2,
e inoculated 5 3 107 C8166 cells with the undiluted
ell-free stock of uncloned SHIVKU-2 whose derivation has
een reported previously (Raghavan et al., 1997; Joag et
l., 1998a). At 96 h postinoculation, cells were harvested
nd the high-molecular-weight chromosomal DNA was
solated as previously described (Blin and Stafford, 1976).
he DNA was digested with EcoRI (SHIV-4 and its deriv-
tives do not have an EcoRI site) and ligated into the
ambda DASH II vector (also digested with EcoRI) using
4 DNA ligase and this was packaged into infectious
hage using commercially available packaging extracts
nd used to infect Escherichia coli (strain XL1 Blue MRA)
o generate recombinant DNA libraries. These recombi-
ant phage were used to infect bacteria on 150-mm
ishes at 10,000 phage per dish, transferred to nitrocel-
ulose filters, and hybridized with a 32P-labeled SHIV
enome probe. Ten recombinant l phage were identified
s containing SHIV sequences. These phage were
laque purified, virus stocks were expanded, and the
NA was isolated and used to transfect C8166 cells
sing standard protocols (Milman and Herzberg, 1981).
our of the 10 clones (clones 2, 3, 4, and 7) caused
ytopathology (cell–cell fusion) and infectious virus (in-
reased amounts of SIV p27) following transfection into
8166 cells. Cell-free virus from clone 4, which we have
esignated SHIVKU-2MC4, was used to prepare virus stocks
T
Detection of SHIV, CMV, and SV-40 Sequ
Tissue
Macaque 44N
SHIV CMV
Frontal cortex (1) (1)
Parietal cortex (1) (2)
Occipital cortex (1) (1)
Temporal cortex (1) (1)
Motor cortex (1) (1)
Hippocampus (1) (2)
Thalamus (1) (1)
Internal capsule (1) (1)
Basal ganglia (1) (1)
Midbrain (1) (2)
Pons (1) (2)
Medulla (1) (1)
Cerebellum (1) (2)
Cervical spinal cord (1) (1)
Thoracic spinal cord (1) (1)
Lumbar spinal cord (1) (1)
a DNA from different regions of the brain was used in nested PCR wi
V-40 genomes.n macaque PBMC. wequence analysis of SHIVKU-2MC4 and uncloned
HIVKU-2
The DNA from the l clone of SHIVKU-2MC4 was isolated
nd purified using standard protocols. Various regions of
he genome were amplified using the oligonucleotides
nd PCR conditions as previously described (Stephens
t al., 1997). The amplified products from three separate
eactions were separated by electrophoresis in a 1%
garose gel, isolated, and molecularly cloned into the
GEM-T vector according to the manufacturer’s instruc-
ions. Plasmids containing the SHIV sequences (one
lone per reaction, three total for each region amplified)
ere sequenced by primer-directed dideoxy sequencing
sing Sequenase enzyme (U.S. Biochemicals, Cleveland,
H) and 35S-dATP. Sequences were compared to HIV-
(HXB2) or SIVmac239 using the PCGENE sequence anal-
sis software program.
Because the env and nef genes had the most nucleotide
ubstitutions in SHIVKU-2MC4, we compared the env and nef
equences of this virus with the consensus sequences
rom the uncloned SHIVKU-2 virus. This was accomplished
y inoculating SHIVKU-2 into PHA-stimulated rhesus ma-
aque PBMC at an m.o.i. of approximately 0.01. At 48 h
ostinoculation, high-molecular-weight DNA was extracted
Blin and Stafford, 1976) and PCR was used to amplify the
nv and the nef regions of the viral genome. For analysis of
p160 sequences, oligonucleotide primers 59 A T G A G A
T G A A G G A G A A A T A T C A G C A C T T G-39 (sense)
nd 59-TTATAGCAAAATCCTTTCCAAGCCC-39 (antisense)
in CNS from Macaques 44N and 44Oa
Macaque 44O
SV-40 SHIV CMV SV-40
(1) (1) (2) (2)
(1) (1) (2) (2)
(1) (1) (2) (2)
(1) (1) (2) (2)
(1) (1) (2) (2)
(2) (1) (2) (2)
(2) (1) (2) (2)
(2) (1) (2) (2)
(1) (1) (2) (2)
(1) (1) (2) (2)
(1) (1) (2) (2)
(1) (1) (2) (2)
(2) (1) (2) (2)
(1) (1) (2) (2)
(2) (1) (2) (2)
(2) (1) (2) (2)
ucleotides that specifically amplified the regions of the SHIV, CMV, orABLE 3
ences
th olignere used, which are complementary to nucleotides 6224
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305ISOLATION OF A PATHOGENIC MOLECULAR CLONE OF SHIVKU-2o 5870 and 8771 to 8795 of the HIV-1 (HXB2) genome
Ratner et al., 1985), respectively. One microgram of
enomic DNA was used in the PCR (Saiki et al., 1985, 1988)
ontaining 1.4 mM MgSO4, 200 mM each of the four de-
xynucleotide triphosphates, 100 pM of each oligonucleo-
ide primer, and a mixture of Taq and Pyrococcus species
B-D polymerases (Elongase, Gibco BRL). The template
as denatured at 94°C for 2 min and PCR amplification
as performed with an automated DNA Thermal Cycler
Perkin–Elmer Cetus) for 35 cycles using the following pro-
ile: denaturation at 94°C for 30 s, annealing at 65°C for 1
in, and primer extension at 68°C for 5 min. Amplification
as completed by incubation for 10 min at 68°C. Three
eparate PCRs were performed for each region of the viral
enome that was studied. For amplification of nef, oligonu-
leotide primers 59-CCACATACCTAGAAGAATAAGA-
AGGG-39 (sense) and 59-ACATCCCCTTGTGGAAAGTC-
CTGCTGTTT-39 (antisense) were used, which are com-
lementary to nucleotides 8746 to 8772 of the HIV-1
HXB2) genome (Ratner et al., 1985) and 9868 to 9898 of
he SIVmac239 genome (Regier and Desrosiers, 1990),
espectively. The conditions for amplification and cloning
f the PCR products were the same as described above.
lasmids containing the env or nef sequences (five total
or env from three separate PCRs and six total for
ef from three separate reactions) were sequenced by
rimer-directed dideoxy sequencing using Sequenase
nzyme (U.S. Biochemicals) and 35S-dATP.
ssessment of macrophage tropism
The macrophage-tropic nature of SHIVKU-2MC4 was as-
essed using the criteria established for cultivation of lym-
hocyte-tropic and a macrophage-tropic SIVmac and SHIV
s reported previously (Stephens et al., 1995, 1997). Blood
as obtained from SIV-seronegative rhesus macaques and
BMC were separated by centrifugation through Ficoll–
ypaque density gradients. The PBMC were seeded into
5-mm dishes at a concentration of 6–8 3 106 cells/dish for
h in 3 ml of R10 FBS. The adherent cells in the dishes
ere replenished with macrophage differentiation medium
MDM), which consisted of RPMI 1640 with 10% human
erum, 15% conditioned L-cell medium, 1025 M 2-mercap-
oethanol, 10 mM HEPES buffer, 5 units/ml macrophage
olony-stimulating factor (Genetics Institute), 100 units/ml of
ranulocyte macrophage colony-stimulating factor (Genet-
cs Institute), and 10 mg/ml gentamicin as described previ-
usly (Stephens et al., 1995) and incubated for at least 7
ays. These cultures were greater than 95% pure (as
udged by staining with anti-CD68, a marker for monocyte/
acrophages). For infection with virus, macrophage cul-
ures in 35-mm dishes were washed three times with RPMI
640, inoculated with 0.1 ml of undiluted virus stocks (con-
aining 104 TCID50 of infectious virus per ml) in 0.5 ml of
DM, and incubated for 2 h at 37°C. Cultures were
ashed three times with MDM, replenished with 3 ml of lresh MDM, and reincubated for up to 11 days. Macro-
hage tropism was assessed by assaying culture medium
t 0, 3, 5, 7, 9, and 11 days for the presence of p27 core
ntigen. Controls included SHIV-4 as a lymphocyte-tropic
irus and SHIVKU-1 as a macrophage-tropic virus in these
tudies (Stephens et al., 1997). All assays were performed
n triplicate and the results shown are typical growth curves
btained following inoculation of rhesus macrophage cul-
ures with these viruses.
oreceptor use studies
A luciferase reporter system was used to determine
hich coreceptors were used by SHIVKU-2MC4 (Chen et al.,
994; Connor et al., 1995). Plasmids encoding: (1) the
L4-3 HIV-1 backbone in which the env has been de-
eted and the luciferase gene has been inserted under
he control of the viral LTR (pNL-luc-E2R2) and (2) various
nv clones were transfected into 293T cells to make
seudotyped reporter viruses that were used to infect
eline CCCs target cells transiently expressing CD4 and
ifferent coreceptors.
To generate a plasmid expressing the SHIVKU-2MC4 en-
elope glycoprotein, the 1208-basepair KpnI–BsaBI frag-
ent containing the V1–V4 region from this virus was
loned into a version of psv7d-SHIV-4 with two mutations
n the V5 loop (N460K, S461K) (Hoffman et al., 1998). This
esulted in an env plasmid in which all amino acid
hanges in the V1–V5 of SHIVKU-2MC4 were introduced in
he context of SHIV-4. Control plasmids included psv7d-
HIV-4 (Hoffman et al., 1998) and pCR3.1-BK28 (a clone
rom SIVmac251) (Edinger et al., 1998a). Fifteen micro-
rams of the env plasmid and 5 mg of pNL-luc-E2R2
ere introduced into 293T cells by calcium phosphate
ransfection to make reporter viruses. At 2 days, the
esulting supernatant containing the viral pseudotypes
as centrifuged to remove contaminating cells and used
o infect target cells or stored at 280°C.
For infection, feline CCCs-CD4 cells, were plated in
4-well plates and transfected with 1.5 mg of each CD4
nd coreceptor plasmids the day prior to infection. Hu-
an CCR2b, CCR3, CCR5, CCR8, CXCR4, STRL33.1,
PR15, APJ, and CD4 were expressed in the pcDNA3
ector (Invitrogen). Human GPR1, CX3CR1, and ChemR23
ere expressed from pRC/CMV, pCR3.1, and pEFIN3,
espectively (Edinger et al., 1998b; Rucker et al., 1997;
amson et al., 1998).
Viral supernatants were added to target cells in the
resence of 8 mg/ml DEAE–dextran in a total volume of
00 ml. Experiments were performed in an equivalent
olume (100 ml) or amount of p24 (67 ng; NEN Life
ciences) for each viral stock added to target cells. The
esults of these two methods were found to be similar.
ells were lysed in 150 ml of 0.5% TX-100 3 days postin-
ection and 50 ml of the resulting lysate was assayed for
uciferase activity.
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306 LIU ET AL.acaques and inoculation procedures
Two 2-year-old rhesus macaques (macaques 44N and
4O) were inoculated intravenously with 1 ml of undiluted
irus stock containing 104 TCID50 of clone 4. The animals
ere housed in our AAALAC-approved animal facility and
valuated weekly for the type of infection that they devel-
ped. Heparinized blood was collected weekly for 4 weeks,
t 2-week intervals for 4 weeks, and monthly thereafter. For
uthanasia, macaques were sedated with ketamine and
eeply anesthetized by intravenous injection of sodium
henobarbital. Following slow exsanguination through the
bdominal aorta, animals were perfused with 1 liter of
aline to flush out excess blood from the vascular compart-
ents of the animals, so as to minimize the risks of viral
NA contamination of solid tissues from the blood.
rocessing of blood and tissue samples
Threefold dilutions of plasma and 10-fold dilutions of
BMC (106 cells/ml) were inoculated into replicate cul-
ures of C8166 in 96-well plates and the cocultures were
xamined for development of cytopathic effects (Joag et
l., 1996). Infectivity titers in plasma were reported as
CID50/ml, and infected cells in the blood were reported
s number of infected cells/106 PBMC. Concentrations of
D41 and CD81 T lymphocytes in the PBMC were eval-
ated by FACS analysis as described previously (Joag et
l., 1996). Virus content in tissues obtained at autopsy
as determined in several tests: (1) cell-free homoge-
ate of different tissues (10% w/v) in R10 FBS were
ssayed for cytopathicity as described for plasma; (2)
ells from lymphoid tissues were separated physically by
ieving and assayed for infectivity as for PBMCs; (3)
ortions of tissues were minced and explanted into cul-
ure in macrophage differentiation medium containing
10 FBS 1 MCSF and GMCSF (Joag et al., 1994, 1996).
uch cultures gave rise to almost pure cultures of tissue
acrophages. Infectivity in supernatant fluids was mea-
ured by cytopathicity assay in C8166 cells. Virus from
uch cultures were considered to be macrophage-tropic.
Brain was divided midsagitally and one-half was fixed in
0% buffered formalin and processed for histopathological
nalysis. The other half was cut into several coronal slices
o facilitate examination of 16 different regions as described
reviously (Raghavan et al., 1997). Portions of these regions
ere frozen for DNA analysis and others were examined for
irus content either by examination of homogenates or by
xplantation of portions of tissue to obtain cultures of brain
acrophages. Slices of kidney were fixed in 10% buffered
ormalin and processed for histopathological analysis as
reviously described (Gattone et al., 1998; Stephens et al.,
998). Sections were evaluated for pathological changes in
lomeruli and tubular regions. Other slices of the kidney
ere frozen and processed for DNA analysis and for pro-
urement of frozen sections for studies on virus replication
n different regions of the kidney. Eenal function studies
For renal function studies, sera were collected at the
ime of inoculation and necropsy. Sera were assessed
or serum urea nitrogen concentration (using a colorimet-
ic assay, Sigma kit 640, Sigma Chemical Co., St. Louis,
O). Urine collected at necropsy (when available) was
ssessed for protein using the Bio-Rad protein assay
Bio-Rad Laboratories, Richmond, CA).
CR analysis for the presence of SHIV, CMV,
nd SV-40 sequences in tissue DNA
Tissues from inoculated animals were screened for
he presence of SHIV sequences using oligonucleotide
rimers specific for SHIV and the PCR technique (Saiki et
l., 1985, 1988). Total cellular genomic DNA was ex-
racted from 5 visceral organs (liver, spleen, mesenteric
ymph node, lung, and kidney) and 16 regions of the brain
nd spinal cord. The DNA was used as a template in
ested PCR to amplify SIV gag sequences that were
ommon to both viruses. The gag-specific oligonucleo-
ides and the conditions for amplification were exactly as
escribed previously (Joag et al., 1994). The oligonucle-
tides and PCR conditions for the detection of cytomeg-
lovirus and SV-40 have been previously described
Raghavan et al., 1997).
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